Q4 FY26 results analysis · May 25, 2026

Poly Medicure Ltd Q4 FY26 Results Analysis: PAT Plunges 29%, EBITDA Margin Misses Targets

−29.2%PAT year on year, Rs. 650.41 Cr
Cofacto ResearchPublished May 25, 20262 min readNegative read
Quick summary

Poly Medicure Ltd's Q4 FY26 numbers came in soft, with revenue of Rs. 5,345.11 Cr (+21.20% YoY) and PAT growth of -29.20% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateMay 25, 2026
QuarterQ4 FY 2025-2026
Revenue (Q4)Rs. 5,345.11 Cr (+21.20% YoY)
PAT (Q4)Rs. 650.41 Cr (-29.20% YoY)
EBITDA margin20.96% (-669 bps YoY)
EPS (Q4)Rs. 6.54 (-26.70% YoY)
Market capRs. 16,190.44 Cr
CMPRs. 1,598.05

Quarter Snapshot

POLYMED's Q4 FY26 consolidated revenue grew 21.2% YoY, but PAT plunged 29.2% YoY as employee costs, depreciation, and finance charges far outpaced revenue. FY26 revenue of 12.3% and EBITDA margin of 23.9% both missed management's own targets of 15% and 25-27% respectively. Acquired subsidiaries remain dilutive and working capital deterioration (receivables up 52% vs 12% revenue growth) raises earnings-quality concerns.

Key Investment Insights

Key Positives

  • Consolidated revenue grew 21.2% YoY in Q4 FY26, accelerating from 16.4% in Q3, driven by domestic momentum and acquisition contributions
  • FY26 standalone PAT grew 1.4% YoY to Rs.33,598 Lakh with EBITDA margin of 26.42%, significantly outperforming consolidated margins
  • Material cost grew only 4.9% YoY vs revenue growth of 12.3%, indicating input cost efficiency
  • QIP proceeds of Rs.50,102 Lakh utilized, with Rs.48,428 Lakh still available for deployment

Risk Factors

  • FY26 revenue growth of 12.3% missed management's 15% guidance target by 270 bps
  • FY26 adjusted EBITDA margin of 23.9% fell 110 bps below the 25% floor of management's 25-27% guidance range
  • Consolidated PAT declined 29.2% YoY in Q4 and 5.3% YoY for FY26 due to cost spikes in employee benefits (+33.4%), depreciation (+38.9%), and finance costs (+52.5%)
  • Free cash flow was negative Rs.6,202 Lakh as CFO of Rs.24,637 Lakh was fully absorbed by capex; working capital outflow of Rs.12,427 Lakh compressed cash generation
  • Trade receivables grew 51.9% YoY, far outpacing revenue growth of 12.3%, indicating extended credit terms
  • Acquired subsidiaries contributed 11.3% of revenue but created a 4.3% drag on PAT, with NCI losses of Rs.141 Lakh

Ask about this

Ask Cofacto a question about this result. Answers cite filings and company data.

Companies on this page
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.